Reverse expression pattern of sirtuin-1 and histone deacetylase-9 in coronary artery disease

Author(s):  
Laleh Heidari ◽  
Sayyed Mohammad Hossein Ghaderian ◽  
Milad Bastami ◽  
Shadi Hosseini ◽  
Saeed Alipour Parsa ◽  
...  
2013 ◽  
Vol 227 (2) ◽  
pp. 244-249 ◽  
Author(s):  
Christa Zollbrecht ◽  
Martina Grassl ◽  
Sabine Fenk ◽  
Regina Höcherl ◽  
Ute Hubauer ◽  
...  

2020 ◽  
Vol 11 ◽  
pp. 204062232091962
Author(s):  
Pérola Michelle Vasconcelos Caribé ◽  
Cristina Cunha Villar ◽  
Guiseppe Alexandre Romito ◽  
Júlio Yoshio Takada ◽  
Ana Paula Pacanaro ◽  
...  

Background: Atherosclerosis and periodontal disease (PD) are inflammatory diseases that have been shown in studies to have a direct association. Mannose-binding lectin (MBL) is an immune system protein that binds to periodontal pathogens favoring phagocytosis. Conversely, increased serum sirtuin-1 (SIRT1) concentration reduces the inflammatory process. Methods: This was a prospective, case-controlled study that analyzed serum concentration of biomarkers in patients with or without coronary artery disease (CAD) and PD. A total of 78 patients were evaluated: 20 healthy individuals, 18 patients with CAD, 20 patients with PD, and 20 patients with both PD and CAD. Clinical and laboratory characteristics were analyzed before and after nonsurgical treatment of PD and also at two equivalent times in patients without PD. Serum MBL and SIRT1 concentration were analyzed by enzyme-linked immunosorbent assay. Results: A negative correlation was observed between changes in serum concentration of MBL and SIRT1 ( r = −0.30; p = 0.006). Comparison between pre- and post-treatment of PD showed a reduction in MBL levels (886.27 ± 906.72 versus 689.94 ± 808.36; p = 0.002) and an increase in SIRT1 values (0.80 ± 1.01 versus 1.49 ± 1.55; p = 0.005) in patients with PD and without CAD. The same result was observed in patients with PD and CAD for MBL and SIRT1, respectively, of 1312.43 ± 898.21 versus 1032.90 ± 602.52 ( p = 0.010) and 1.32 ± 1.0 versus 1.82 ± 1.75 ( p = 0.044). Conclusion: PD treatment reduced MBL serum concentration and increased SIRT1 serum concentration in patients with and without CAD.


2017 ◽  
Vol 263 ◽  
pp. e53
Author(s):  
Ilias Doulamis ◽  
Aspasia Tzani ◽  
Panagiotis Konstantopoulos ◽  
Anastasios Gkogkos ◽  
George Samanidis ◽  
...  

2017 ◽  
Vol 230 ◽  
pp. 447-453 ◽  
Author(s):  
Ilias P. Doulamis ◽  
Aspasia I. Tzani ◽  
Panagiotis S. Konstantopoulos ◽  
George Samanidis ◽  
Georgios Georgiopoulos ◽  
...  

2016 ◽  
Vol 27 (4) ◽  
pp. 213-217 ◽  
Author(s):  
P Ramkaran ◽  
A Phulukdaree ◽  
S Khan ◽  
D Moodley ◽  
AA Chuturgoon

Health ◽  
2012 ◽  
Vol 04 (12) ◽  
pp. 1448-1456 ◽  
Author(s):  
Ian James Martins ◽  
Andrea. C. Wilson ◽  
Wei Ling Florence Lim ◽  
Simon. M. Laws ◽  
Stephanie. J. Fuller ◽  
...  

Author(s):  
AL-Shabrawy M. Abdelnabi ◽  
Imam M. Esmayel ◽  
Samia Hussein ◽  
Reham M. Ali ◽  
Alhoussein Alsayed AbdelAal

Abstract Background Coronary artery disease (CAD) represents the leading cause of death worldwide. Animal and human studies have demonstrated that silent information regulator 1 (SIRT1) is involved in a wide range of physiological and pathological processes. This study aimed to measure the plasma level of SIRT1 in patients with CAD and explore its correlation with cardiovascular risk factors. Results Plasma SIRT1 was significantly lower in patients with chronic coronary syndrome (CCS) than in those in the control group and was significantly lower in patients with both acute myocardial infarction and unstable angina than in those in the control group and with CCS. Moreover, plasma SIRT1 was positively correlated with platelet count and negatively correlated with cholesterol and triglyceride levels. Conclusions The plasma level of SIRT1 is lower in patients with CAD compared to control and it could be a possible marker for this disease. Multi-center studies with follow-up measurements are recommended for further investigation.


2019 ◽  
Vol 133 (22) ◽  
pp. 2283-2299
Author(s):  
Apabrita Ayan Das ◽  
Devasmita Chakravarty ◽  
Debmalya Bhunia ◽  
Surajit Ghosh ◽  
Prakash C. Mandal ◽  
...  

Abstract The role of inflammation in all phases of atherosclerotic process is well established and soluble TREM-like transcript 1 (sTLT1) is reported to be associated with chronic inflammation. Yet, no information is available about the involvement of sTLT1 in atherosclerotic cardiovascular disease. Present study was undertaken to determine the pathophysiological significance of sTLT1 in atherosclerosis by employing an observational study on human subjects (n=117) followed by experiments in human macrophages and atherosclerotic apolipoprotein E (apoE)−/− mice. Plasma level of sTLT1 was found to be significantly (P<0.05) higher in clinical (2342 ± 184 pg/ml) and subclinical cases (1773 ± 118 pg/ml) than healthy controls (461 ± 57 pg/ml). Moreover, statistical analyses further indicated that sTLT1 was not only associated with common risk factors for Coronary Artery Disease (CAD) in both clinical and subclinical groups but also strongly correlated with disease severity. Ex vivo studies on macrophages showed that sTLT1 interacts with Fcɣ receptor I (FcɣRI) to activate spleen tyrosine kinase (SYK)-mediated downstream MAP kinase signalling cascade to activate nuclear factor-κ B (NF-kB). Activation of NF-kB induces secretion of tumour necrosis factor-α (TNF-α) from macrophage cells that plays pivotal role in governing the persistence of chronic inflammation. Atherosclerotic apoE−/− mice also showed high levels of sTLT1 and TNF-α in nearly occluded aortic stage indicating the contribution of sTLT1 in inflammation. Our results clearly demonstrate that sTLT1 is clinically related to the risk factors of CAD. We also showed that binding of sTLT1 with macrophage membrane receptor, FcɣR1 initiates inflammatory signals in macrophages suggesting its critical role in thrombus development and atherosclerosis.


Sign in / Sign up

Export Citation Format

Share Document